SAVA Live-Signale | Maximieren Sie Profite mit Getagraph.com

KAUFEN 107901 min ago

@ $24.09

Ausgestellt: 14 Feb 2024 @ 21:43

Rendite: -8.18%

Vorheriges Signal: Feb 13 - 21:46

Vorheriges Signal: Verkaufen

Rendite: 0.75 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 21:04):

Stats
Tagesvolumen	662 746
Durchschnittsvolumen	742 488
Marktkapitalisierung	956.14M
EPS	$0 ( 2024-02-27 )
Nächstes Ertragsdatum	( $-0.510 ) 2024-05-06
Last Dividend	$5.25 ( 2012-12-13 )
Next Dividend	$0 ( N/A )
P/E	-9.53
ATR14	$0.0330 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-23	Barry Richard	Buy	176 085	Common Stock
2024-01-03	Barry Richard	Buy	117 390	Common Stock Warrant
2024-04-23	Barry Richard	Sell	117 390	Common Stock Warrant
2024-04-18	Kupiec James William	Buy	1 500	Common Stock
2024-01-03	Kupiec James William	Buy	1 000	Common Stock Warrant

INSIDER POWER
68.79
Last 91 transactions
Buy: 2 039 016 \| Sell: 658 296

Volumen Korrelation

Lang: -0.07 (neutral)

Kurz: -0.42 (neutral)

Signal:(36.587) Neutral

Cassava Sciences Inc Korrelation

10 Am meisten positiv korreliert
CBIO	0.848
GOOD	0.844
ALXO	0.828
ANGN	0.828
CTBI	0.825
MIRO	0.819
RPRX	0.813
CMPX	0.813
DCRC	0.808
BLUE	0.806

10 Am meisten negativ korreliert
RNA	-0.87
VKTX	-0.844
BWMX	-0.833
MTRY	-0.832
DKDCA	-0.826
CFFE	-0.823
ROCL	-0.821
LRMR	-0.821
AMPH	-0.814
EDTX	-0.811

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Cassava Sciences Inc Korrelation - Währung/Rohstoff

0.24
( neutral )

0.25
( neutral )

0.00
( neutral )

0.04
( neutral )

-0.61
( weak negative )

Cassava Sciences Inc Finanzdaten

Annual	2023
Umsatz:	$0
Bruttogewinn:	$-1.53M (0.00 %)
EPS:	$-2.32

FY	2023
Umsatz:	$0
Bruttogewinn:	$-1.53M (0.00 %)
EPS:	$-2.32

FY	2022
Umsatz:	$-1 800.00
Bruttogewinn:	$-1.30M (72 377.78 %)
EPS:	$-1.800

FY	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Cassava Sciences Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$14.00	2010-12-13
Last Dividend	$5.25	2012-12-13
Next Dividend	$0	N/A
Payout Date	2012-12-24
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$19.25	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-04)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2010	$14.00	37.20%
2011	$0	0.00%
2012	$5.25	19.20%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-40.28	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.624	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.560	1.500	-7.33	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	9.13	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.60	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.53	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-1.944	2.00	-0.648	-1.296	[0 - 30]
freeCashFlowPerShareTTM	-1.954	2.00	-0.977	-1.954	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.348	1.000	7.53	7.53	[0.2 - 0.8]
operatingProfitMarginTTM	-45.29	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0155	0.800	-3.23	-2.58	[0.5 - 2]
Total Score				-1.853

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-9.96	1.000	-1.108	0	[1 - 100]
returnOnEquityTTM	-0.560	2.50	-4.71	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.954	2.00	-0.651	-1.954	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.944	2.00	-0.648	-1.296	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.794	1.500	1.376	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-34.93	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.16

Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Echtzeitaktualisierungen für Cassava Sciences Inc [SAVA]

Upcoming Earnings Alert

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)